The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy outcomes of CDK4/6 inhibitors plus endocrine therapy versus chemotherapy in HR+/HER2- breast cancer: A systematic review and meta-analysis.
 
Raelson Miranda
No Relationships to Disclose
 
Gabrielle Trofa
No Relationships to Disclose
 
Luisa Costa
No Relationships to Disclose
 
Laura Testa
Consulting or Advisory Role - AstraZeneca; AstraZeneca; Daiichi Sankyo/Astra Zeneca; Daiichi Sankyo/Astra Zeneca; MSD Oncology; MSD/AstraZeneca; Novartis; Pfizer
Speakers' Bureau - Daiichi Sankyo/Astra Zeneca; Lilly; Novartis
Research Funding - Novartis (Inst)
Travel, Accommodations, Expenses - Daiichi Sankyo/Astra Zeneca; Gilead Sciences; MSD Oncology; Roche